FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

GALLISPAT

26.9
-0.55 (-2%)
Updated 12:56 05/08 IST

GALLISPAT Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for GALLISPAT
Disclaimer
0% Bullish
0% Bearish

GALLISPAT Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See GALLISPAT Share Price Targets >>

GALLISPAT Ratings

Long term GALLISPAT rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live GALLISPAT message board: Is GALLISPAT buy or sell? Should I buy GALLISPAT shares? Why are GALLISPAT shares falling? Should I invest in GALLISPAT stock?

  1. Home
  2. GALLISPAT Forum

GALLISPAT Share Price Discussion

N
Reputation: 4,537 • Jul 29 4:33 AM
GlaxoSmithKline Standalone June 2020 Net Sales at Rs 648.65 crore, down 17.69% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 4,537 • Jul 29 4:33 AM
GlaxoSmithKline Consolidated June 2020 Net Sales at Rs 648.59 crore, down 17.69% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 4,537 • Jul 29 1:43 AM
GlaxoSmithKline Pharmaceuticals Q1 net profit declines 2.38% to Rs 111 crore
The company had posted a net profit of Rs 113.54 crore in the corresponding period previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing.
Moneycontrol
Like
Reply
N
Reputation: 4,537 • Jun 29 4:03 AM
Immunity booster for your portfolio! Here's a list of 10 stocks to get through COVID times
India's long-term fundamental stories for discretionary and consumption are intact, and sectors such as IT, Pharmaceuticals, Bank, Cement, Gas, Capital Goods, and insurance are expected to be the new leaders.
Moneycontrol
Like
Reply
N
Reputation: 4,537 • Jun 11 10:43 AM
GSK is world's largest vaccine maker. Yet it has been tame with its COVID-19 strategy
GSK is betting on its adjuvant technology to support companies developing COVID-19 vaccines.
Moneycontrol
Like
Reply
N
Reputation: 4,537 • May 21 2:48 AM
GlaxoSmithKline Consolidated March 2020 Net Sales at Rs 775.80 crore, up 3.28% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 4,537 • May 19 3:28 AM
GlaxoSmithKline Consolidated March 2020 Net Sales at Rs 775.80 crore, up 3.28% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 4,537 • May 18 2:18 AM
GlaxoSmithKline Pharma Q4 net profit declines 6% to Rs 138 crore
For the fiscal year ended March this year, the company posted a net profit of Rs 93.20 crore as against Rs 445.39 crore in the previous fiscal, the filing said.
Moneycontrol
Like
Reply
N
Reputation: 4,537 • May 7 8:23 AM
GlaxoSmithKline sells $3.35 billion stake in Hindustan Unilever
The funds will help GSK in its goal of reinvigorating its drug development pipeline, having made costly bets on experimental cancer treatments and future cell and gene therapies amid sluggish revenue growth.
Moneycontrol
Like
Reply
N
Reputation: 4,537 • May 5 12:58 PM
Hot Stocks | Glaxo Pharma, M&M, Tata Comm three buy ideas for short term
In the week gone by, Nifty took out the crucial resistance of 9,390, which will interchange its role as immediate resistance.
Moneycontrol
Like
Reply
N
Reputation: 4,537 • Apr 15 12:38 PM
Hot Stocks | Three stock ideas for the short term
By surpassing the resistance of 8,600 in the previous week, Nifty also confirmed the bullish inverse head and shoulder pattern breakout on the daily line charts.
Moneycontrol
Like
Reply
N
Reputation: 4,537 • Apr 2 1:43 AM
Trade Setup for Friday: Top 15 things to know before Opening Bell
Key support level for Nifty is placed at 8,105.4, followed by 7,957. If the index starts moving up, key resistance levels to watch out for are 8,495.15 and 8,736.5.
Moneycontrol
Like
Reply
N
Reputation: 4,537 • Mar 4 11:18 AM
MNC drug body OPPI names Sharad Tyagi as President
Tyagi is currently Managing Director, Boehringer Ingelheim India. He replaces A Vaidheesh of GSK.
Moneycontrol
Like
Reply
N
Reputation: 4,537 • Mar 4 9:03 AM
Sridhar Venkatesh appointed as GSK India MD, VP
Venkatesh has more than 24 years of diverse experience in pharmaceuticals and healthcare, and has a strong track record of success in multiple roles within GSK, it added.
Moneycontrol
Like
Reply
N
Reputation: 4,537 • Feb 10 12:28 PM
Ranitidine recall forces GSK to alter Indian market strategy
GSK had initiated global voluntary recall of Ranitidine in September 2019, following reports of a probable cancer causing impurity called N‐nitrosodimethylamine (NDMA).
Moneycontrol
Like
Reply
N
Reputation: 4,537 • Feb 7 5:28 AM
GlaxoSmithKline Consolidated December 2019 Net Sales at Rs 778.59 crore, down 5.63% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 4,537 • Feb 5 3:18 AM
GlaxoSmithKline Standalone December 2019 Net Sales at Rs 778.68 crore, down 5.65% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 4,537 • Feb 4 5:13 AM
GSK Pharma share price tanks 10% to hit 3-month low after Q3 loss of Rs 661 crore
The results were impacted due to voluntary global recall of ranitidine products, including Zinetac, said GlaxoSmithKline Pharmaceuticals Managing Director A Vaidheesh.
Moneycontrol
Like
Reply
N
Reputation: 4,537 • Feb 3 2:18 AM
GlaxoSmithKline Pharma posts net loss of Rs 661.16cr for December quarter
The company had posted a net profit of Rs 113.67 crore for the corresponding period of the previous financial year, GlaxoSmithKline Pharmaceuticals said in a filing to the BSE.
Moneycontrol
Like
Reply
N
Reputation: 4,537 • Oct 23, 2019 5:48 AM
GlaxoSmithKline Consolidated September 2019 Net Sales at Rs 882.02 crore, up 0% Y-o-Y
Moneycontrol
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • GALLISPAT - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization851.44
    Enterprise Value1,090.09
    Price to Earnings14.12
    Price to Book Value1.11
    Return on Capital Employed0.11
    Return on Equity0.12
    Face Value1
    Dividend YieldNA
  • GALLISPAT Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Aug 427.228.2525.327.45
    Aug 327.7527.8526.8527.2
    Jul 3127.527.726.4526.95
    Jul 3027.6528.226.826.95
    Jul 2927.927.927.227.65
  • GALLISPAT Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹28.32
    30 Day Moving Average₹28.91
    50 Day Moving Average₹27.67
    100 Day Moving Average₹23.94
    200 Day Moving Average₹23.23
  • GALLISPAT - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue575424.710.35
    Operating Profit9252.150.76
    Profit Before Tax6746.050.45
    Net Income5444.250.22
  • GALLISPAT - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds7644460.71
    Total Liabilities284563-0.5
    Total Assets1,0481,0100.04
  • GALLISPAT - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity7619.172.96
    Cash from Investing Activity-157-32.913.77
    Cash from Financing Activity8111.915.8
    Net Cash FlowNA-1.83-1
  • GALLISPAT - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.050.06
    Return on Equity0.120.11
    Return on Capital Employed0.110.11
  • GALLISPAT - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.03
    3 Year CAGR Growth in Operating Profit0.78
    3 Year CAGR Growth in EBIDTA0.73
    3 Year CAGR Growth in Net Income0.99
    3 Yr CAGR Growth - Diluted EPS-0.8
  • GALLISPAT - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.4
    5 Year CAGR Growth in Operating Profit2.05
    5 Year CAGR Growth in EBIDTA0.78
    5 Year CAGR Growth in Net Income3.6
    3 Yr CAGR Growth - Diluted EPS3.37
  • GALLISPAT - Recent News

    keyboard_arrow_down
    NewsBot
    Jul 29 4:33 AM
    GlaxoSmithKline Standalone June 2020 Net Sales at Rs 648.65 crore, down 17.69% Y-o-Y
    Moneycontrol
    NewsBot
    Jul 29 4:33 AM
    GlaxoSmithKline Consolidated June 2020 Net Sales at Rs 648.59 crore, down 17.69% Y-o-Y
    Moneycontrol
    NewsBot
    Jul 29 1:43 AM
    GlaxoSmithKline Pharmaceuticals Q1 net profit declines 2.38% to Rs 111 crore
    Moneycontrol
    NewsBot
    Jun 11 10:43 AM
    GSK is world's largest vaccine maker. Yet it has been tame with its COVID-19 strategy
    Moneycontrol
    NewsBot
    May 21 2:48 AM
    GlaxoSmithKline Consolidated March 2020 Net Sales at Rs 775.80 crore, up 3.28% Y-o-Y
    Moneycontrol
    NewsBot
    May 19 3:28 AM
    GlaxoSmithKline Consolidated March 2020 Net Sales at Rs 775.80 crore, up 3.28% Y-o-Y
    Moneycontrol
    NewsBot
    May 18 2:18 AM
    GlaxoSmithKline Pharma Q4 net profit declines 6% to Rs 138 crore
    Moneycontrol
    NewsBot
    May 7 8:23 AM
    GlaxoSmithKline sells $3.35 billion stake in Hindustan Unilever
    Moneycontrol
    NewsBot
    May 5 12:58 PM
    Hot Stocks | Glaxo Pharma, M&M, Tata Comm three buy ideas for short term
    Moneycontrol
    NewsBot
    Apr 15 12:38 PM
    Hot Stocks | Three stock ideas for the short term
    Moneycontrol
  • GALLISPAT - Related Communities

    keyboard_arrow_down
    Tata Steel Ltd. NSE: TATASTEEL | BSE:...
    JSW Steel Ltd. NSE: JSWSTEEL | BSE: 5...
    Jindal Steel & Power Ltd. NSE: JINDAL...
    Steel Authority of India Ltd. NSE: SA...
    Jindal Saw Ltd. NSE: JINDALSAW | BSE:...
    Mishra Dhatu Nigam Ltd. NSE: MIDHANI ...
    Jai Corp Ltd. NSE: JAICORPLTD | BSE: ...
    Welspun Corp Ltd. NSE: WELCORP | BSE:...
    Tata Steel Long Products Ltd. NSE: TA...
    Tata Metaliks Ltd. NSE: TATAMETALI | ...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020